Drug use patterns in the presence of crack in downtown Montréal

Drug and Alcohol Review

Volumn 31, Issue 1, 2012, Pages 72-80

  Roy, Elise ^a,b   Arruda, Nelson ^d   Vaillancourt, Eric ^a   Boivin, Jean Francois ^c   Morissette, Carole ^b   Leclerc, Pascale ^b   Alary, Michel ^d   Bourgois, Philippe ^e  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b Montreal Health and Social Services Agency   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e Richard Perry University   (United States)

Author keywords

Crack cocaine; Hepatitis C risk behaviour; HIV risk behaviour; Mixed methods study; Mode of drug consumption

Indexed keywords

COCAINE;

ADOLESCENT; ADULT; ARTICLE; CANADA; COCAINE DEPENDENCE; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; MALE; MIDDLE AGED; OPIATE ADDICTION; POWDER; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; COCAINE-RELATED DISORDERS; CRACK COCAINE; DATA COLLECTION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; POWDERS; QUEBEC; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84855331028     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2011.00299.x     Document Type: Article

References (47)

1. ASPC (Agence de la santé publique du Canada). I-Track-Surveillance améliorée des comportements à risque chez les utilisateurs de drogues injectables au Canada-Rapport sur l'enquête pilote. 2004. Available at: (accessed November 2008).
2. Parent R, Alary M, Morissette C, Roy É, Leclerc P. Surveillance des maladies infectieuses chez les utilisateurs de drogue par injection-Épidémiologie du VIH de 1995 à 2007-Épidémiologie du VHC de 2003 à 2007. Institut national de santé publique du Québec. 2008. Available at: (accessed February 2009).
3. ASPC (Agence de la santé publique du Canada). I-Track-Surveillance améliorée des comportements à risque chez les utilisateurs de drogues injectables au Canada-Rapport sur la phase I. 2006. Available at: (accessed October 2008).
4. Hudgins R, McCusker J, Stoddard A. Cocaine use and risky injection and sexual behaviors. Drug Alcohol Depend 1995;37:7-14.
5. Bourgois P, Bruneau J. Needle exchange, HIV infection and the politics of science: confronting Canada's cocaine injection epidemic with participant observation. Med Anthropol 2000;18:325-50.
6. Patrick DM, Tyndall MW, Cornelisse PGA, etal. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. Can Med Assoc J 2001;165:889-95.
7. Tyndall M, Spittal P, Li K, Wood E, O'Shaughnessy MV, Schechter MT. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 2003;17:887-93.
8. Maher L, Jalaludin B, Chant KG, etal. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction 2006;101:1499-508.
9. Roy É, Alary M, Morissette C, etal. High HCV prevalence and incidence among Canadian IDUs. Int J STD AIDS 2007;18:23-7.
10. Hankins C, Alary M, Parent R, Blanchette C, Claessens C, SurvUDI Working Group. Continuing HIV transmission among injection drug users in Eastern Central Canada: the SurvUDI study, 1995 to 2000. J Acquir Immune Defic Syndr 2002;30:514-21.
11. Bourgois P. Crack and the political economy of social suffering. Addict Res Theory 2003;11:31-7.
12. Bourgois P. In search of respect: selling crack in El Barrio. New York: Cambridge University Press, 2003.
13. Inciardi JA, Surratt HL, Pechansky F, etal. Changing patterns of cocaine and HIV risks in the south of Brazil. J Psychoactive Drugs 2006;38:305-10.
14. van Ameijden EJ, Coutinho RA. Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitions. J Epidemiol Community Health 2001;55:356-3.
15. De Beck K, Kerr T, Li K, etal. Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs. Can Med Assoc J 2009;181:585-9.
16. Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Soc Sci Med 2005;61:1026-44.
17. Sterk CE, Elifson KW. Fluctuating drug markets and HIV risk taking: female drug users and their relationship with drug markets. Med Anthropol 2000;18:439-55.
18. Ciccarone D. Heroin in brown, black and white: structural factors and medical consequences in the US heroin market. Int J Drug Policy 2009;20:277-82.
19. Gamella JF. The spread of intravenous drug use and AIDS in a neighborhood in Spain. Med Anthropol 1994;8:31-160.
20. Stimson GV, Choopanya K. Global perspectives on drug injecting. In: Stimson G, Des Jarlais DC, Ball A, eds. Drug injecting and HIV infection: global dimensions and local responses. London: UCL Press, 1998:1-22.
21. Weeks MR, Clair S, Singer M, etal. High Risk drug use sites, meaning and Practice: implications for AIDS prevention. J Drug Issues 2001;31:781-801.
22. Deren S, Oliver-Velez D, Finlinson A, etal. Integrating qualitative and quantitative methods: comparing HIV-related risk behaviors among Puerto Rican drug users in Puerto Rico and New York. Subst Use Misuse 2003;38:1-24.
23. Koester S, Glanz J, Barón A. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav 2005;9:27-39.
24. Bourgois P, Martinez A, Kral A, Edlin BR, Schonberg J, Ciccarone D. Reinterpreting ethnic patterns among white and African American men who inject heroin: a social science of medicine approach. PLoS Med 2006;3:e452.
25. Kubicek K, Weiss G, Iverson EF, Kipke MD. Deconstructing the complexity of substance use among young men who have sex with men (YMSM) by optimizing the role of qualitative strategies in a mixed methods study. Subst Use Misuse 2010;45:754-76.
26. Bourgois P. Anthropology and epidemiology on drugs: the challenges of cross-methodological and theoretical dialogue. Int J Drug Policy 2002;13:259-69.
27. Creswell JW, Plano Clark VL. Designing and conducting mixed methods research. Thousand Oaks: Sage, 2007.
28. Biernacki P, Waldorf D. Snowball sampling: problems and techniques in chain referral. Sociol Methods Res 1981;10:141-63.
29. Laperrière A. La théorisation ancrée (grounded theory): démarche analytique et comparaison avec d'autres approches apparentées. In: Poupart J, Deslauriers JP, Groulx LH, etal, eds. La recherche qualitative. Enjeux épistémologiques et méthodologiques. Paris: Gaëtan Morin, 1997:309-32.
30. Bourgois P. Ethnographic visit to Montréal. Ottawa: Division of HIV Epidemiology Research, Bureau of HIV/AIDS and STD, Laboratory Centre for Disease Control, Health/Santé Canada, 1997.
31. de la Fuente L, Saavedra P, Barrio G, Royuela L, Vicente J. Temporal and geographic variations in the characteristics of heroin seized in Spain and their relation with the route of administration. Drug Alcohol Depend 1996;40:185-94.
32. Sotheran JL, Goldsmith DS, Blasco M, Friedman SR. Heroin sniffing as self-regulation among injecting and non-injecting heroin users. J Drug Issues 1999;29:401-22.
33. Clatts MC, Welle DL, Goldsamt LA, Lankenau SE. An ethno-epidemiological model for the study of trends in illicit drug use: reflections on the 'emergence' of crack injection. Int J Drug Policy 2002;13:285-96.
34. Fischer B, Rehm J, Patra J, etal. Crack across Canada: comparing crack users and crack non-users in a Canadian multi-city cohort of illicit opioid users. Addiction 2006;101:1760-70.
35. Firestone M, Fischer B. A qualitative exploration of prescription opioid injection among street-based drug users in Toronto: behaviors, preferences and drug availability. Harm Reduct J 2008;5:30.
36. Leri F, Bruneau J, Stewart J. Understanding polydrug use: review of heroin and cocaine co-use. Addiction 2003;98:7-22.
37. Chitwood DD, Comerford M, Weatherby NL. The initiation of the use of heroin in the age of crack. Heroin in the age of crack-cocaine. In: Inciardi JA, Harrisson LD, eds. Drugs, health and social policy series, Vol. 6. Thousand Oaks: Sage Publications, 1998:51-76.
38. Davis WR, Johnson BD. Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug Alcohol Depend 2008;92:267-76.
39. Hope V, Kimber J, Vickerman P, Hickman M, Ncube F. Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England. BMC Infect Dis 2008;8:120.
40. Gordon RJ, Lowy FD. Bacterial infections in drug users. N Eng J Med 2005;353:1945-54.
41. Roy É, Denis V, Gutiérrez N, Haley N, Morissette C, Boudreau JF. Evaluation of a media campaign aimed at preventing initiation into drug injection among street youth. Drugs Educ Prev Policy 2007;14:401-14.
42. Hunt N, Stillwell G, Taylor C, Griffiths P. Evaluation of a brief intervention to reduce initiation into injecting. Drugs Educ Prev Policy 1998;5:185-93.
43. Des Jarlais DC, Casriel C, Friedman SR, Rosenblum A. AIDS and the transition to illicit drug injection-results of a randomized trial prevention program. Br J Addict 1992;87:493-8.
44. Manchikanti L. Prescription drug abuse: what is being done to address this new drug epidemic? Testimony before the subcommittee on criminal justice, drug policy and human resources. Pain Physician 2006;9:287-321.
45. McCarthy M. Prescription drug abuse up sharply in the USA. Lancet 2007;369:1505-6.
46. Strassels SA. Economic burden of prescription opioid misuse and abuse. J Manag Care Pharm 2009;15:556-62.
47. Sterk CE, Dolan K, Hatch S. Epidemiological indicators and ethnographic realities of female cocaine use. Subst Use Misuse 1999;34:2057-72.